HONG KONG – Researchers from the Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU) have developed a DNA vaccine against malignant mesothelioma that elicited complete and long-lasting protection against malignancy, while curing pre-existing tumors in mouse models.